| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 11/01/2001 | WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 11/01/2001 | US20010036946 Antiinflammatory agents |
| 11/01/2001 | US20010036930 Therapeutic azide compounds |
| 11/01/2001 | US20010036652 Diels-Alder process; antitumor agents |
| 10/31/2001 | EP1044201A4 3-substituted adenines via2-thioxanthines |
| 10/30/2001 | US6310205 Intermediates for preparing 3-substituted adenines and 3,8-di-substituted 6-aminopurine derivatives for use as phosphodiesterase inhibitors. |
| 10/30/2001 | US6310070 For treating nephritis, improving proteinuria due to glomerulonephritis and preventing aggravation of nephritis |
| 10/25/2001 | WO2001079188A1 Antihistaminic compounds |
| 10/25/2001 | WO2000061541A8 Pharmaceutical compounds |
| 10/24/2001 | EP1147108A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
| 10/24/2001 | EP0775142B1 Substituted o6 -benzylguanines |
| 10/23/2001 | US6307054 Process for preparing 2,4- dihydroxypyridine and 2,4- dihydroxy-3-nitropyridine |
| 10/23/2001 | CA2079342C Multi-functional pharmaceutical compounds and methods of use |
| 10/18/2001 | WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 10/18/2001 | WO2001077101A1 Chemical compounds |
| 10/18/2001 | WO2001077075A2 Inhibitors of inflammation and reperfusion injury |
| 10/18/2001 | WO2001076607A1 Dry syrup containing theophylline sustained release microcapsules |
| 10/18/2001 | CA2403012A1 Chemical compounds |
| 10/17/2001 | EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors |
| 10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
| 10/17/2001 | EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 10/16/2001 | US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 10/16/2001 | US6303618 Cyclin dependent kinase inhibiting purine derivatives |
| 10/16/2001 | US6303617 Serotonin-like 9-substituted hypoxanthine and methods of use |
| 10/16/2001 | US6303614 Tetrahydro gamma-carbolines |
| 10/16/2001 | US6303604 Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase |
| 10/11/2001 | US20010029237 A bicyclic triazole or diazole containing sulfonyl or phosphine oxide or thiophosphorus derivatives; useful as bactericide and fungicide in crop protection |
| 10/10/2001 | EP1142893A1 Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1140937A2 Antiviral nucleoside analogues |
| 10/10/2001 | EP1140737A2 System and method for structure-based drug design that includes accurate prediction of binding free energy |
| 10/10/2001 | CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 10/09/2001 | US6300335 Urogenital disorders |
| 10/04/2001 | WO2001073438A1 Ricin inhibitors and methods for use thereof |
| 10/04/2001 | WO2001073095A2 Preparation of deoxynucleosides |
| 10/04/2001 | WO2001049688A8 Purine derivatives, process for their preparation and use thereof |
| 10/04/2001 | US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias |
| 10/04/2001 | US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases |
| 10/04/2001 | US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab |
| 10/04/2001 | EP1087962A4 Preparation of heteroaryl compounds |
| 10/02/2001 | US6297253 Inactivating a nuclear localization signal of a protein comprising contacting the protein with an aryl carbonyl compound that forms stable reversible covalent interactions with neighboring basic amino acid residues |
| 10/02/2001 | US6297226 Treating a disease or a condition in a mammal treatable by inhibiting the activity of a monoamine oxidase |
| 09/27/2001 | WO2001004134A3 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |
| 09/27/2001 | WO2000061537A3 Pharmaceutical compounds |
| 09/26/2001 | EP1135134A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 09/26/2001 | EP0775141B1 Phenyl xanthine derivatives |
| 09/26/2001 | CN1314910A Adenosine derivatives |
| 09/26/2001 | CN1071572C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294541 Purine derivatives having phosphodiesterase IV inhibition activity |
| 09/25/2001 | US6294540 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 09/20/2001 | WO2001068600A2 Benzylated pde4 inhibitors |
| 09/20/2001 | CA2402384A1 Benzylated pde4 inhibitors |
| 09/19/2001 | EP0885223B1 Pharmaceutical compositions comprising famciclovir monohydrate |
| 09/19/2001 | EP0877746B1 Process for preparing purine derivatives |
| 09/19/2001 | EP0853616B1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 09/19/2001 | CN1313858A Manufacture of 1,3-oxathiolane nucleosides |
| 09/18/2001 | US6291476 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 09/12/2001 | EP1131323A1 Synthesis of acyclic nucleoside derivatives |
| 09/12/2001 | EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof |
| 09/11/2001 | US6288236 Benzimidazole compounds containing a benzoxazole or benzothiazole ring, and compositions and methods of use containing the same |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288069 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 09/07/2001 | WO2001064676A2 INHIBITORS OF p38-α KINASE |
| 09/06/2001 | US20010020089 Purine derivatives |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/23/2001 | WO2001060835A1 Purine derivatives |
| 08/23/2001 | WO2001060824A1 Xanthine derivatives, intermediates and use for treating osteoporosis |
| 08/23/2001 | CA2400619A1 Purine derivatives |
| 08/22/2001 | EP1124562A1 Combination therapy to treat hepatitis b virus |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058894A1 Stereoselective synthesis of nucleoside analogues |
| 08/16/2001 | WO2001058241A2 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 08/16/2001 | WO2001010380A3 Benzanilides as potassium channel openers |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
| 08/09/2001 | WO2001056988A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 08/08/2001 | EP1121372A1 Adenine derivatives |
| 08/08/2001 | EP1121366A1 Prodrugs of phosphorous-containing pharmaceuticals |
| 08/08/2001 | EP1121130A2 Zinc finger-reactive antimicrobial compounds |
| 08/08/2001 | CN1069316C Substituted 5-ring heterocycles, their preparation and use |
| 08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
| 08/07/2001 | US6271212 Mixture with carrier |
| 08/07/2001 | US6271041 Forming mixture containing metal-contining electrochemiluminescent moiety; amine or amine compoundand electrolyte; exposing to electrochemical energy so that electrochemiluminescence is emitted; detecting luminescence |
| 08/02/2001 | WO2001055095A1 Functional monomers for molecular recognition and catalysis |
| 08/02/2001 | WO2001054731A2 Ligand conjugates and methods for preparing same |
| 08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | CA2398435A1 Novel ligands and methods for preparing same |
| 08/02/2001 | CA2397754A1 Nitrate salts of antimicrobial agents |
| 08/01/2001 | EP1120417A2 Xanthine derivatives for the treatment of cerebrovascular disorders |
| 08/01/2001 | EP1119571A2 Tricyclic delta3-piperidines as alpha2-antagonists |
| 08/01/2001 | CN1306426A Use of compounds for anti-pruritic activity |
| 07/31/2001 | US6268373 Trisubstituted thioxanthines |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |